$WM

Oppenheimer reiterates Waste Management stock rating after Q3 results

Oppenheimer reiterated an Outperform rating and $263 price target for Waste Management (NYSE:WM) after Q3 results. Shares fell as adjusted EBITDA missed estimates, though revenue beat. The company adjusted guidance, citing margin headwinds. Analysts see 13% upside potential. Waste Management trades at a P/E of 31.91, with some analysts suggesting overvaluation. Jefferies lowered its target to $267, citing margin pressures.

Original reporting
Published Oct 29, 2026, 10:56 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 11:45 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$WM
Bearish
high confidence
Mentioned
$WM
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$WMBearishHigh
01

Why it matters

The earnings miss may trigger short-term selling, but the reaffirmed target indicates potential upside on longer-term fundamentals.

02

Market read

Primary earnings disclosure for a large-cap waste services company with actionable rating guidance.

03

What to watch

Renewable natural gas contributions and WMHS synergies could offset short-term margin headwinds.

Relevance 8/10Novelty 8/10Timing: post-market Wednesday

Background

Waste Management (WM) released its Q3 2026 earnings, missing EBITDA expectations but beating revenue forecasts, prompting Oppenheimer to reaffirm its Outperform rating.

Company-level read

Ticker impact

$WMBearishHigh confidence
Context

Oppenheimer reiterated an Outperform rating with a $263 price target after Waste Management reported Q3 results showing adjusted EBITDA miss and mixed revenue/earnings numbers.

Expected impact

likely pressure as the market prices in the margin miss

Evidence & confidence

The earnings miss is new information and the rating reiteration provides a clear catalyst for traders.

Market effects

Waste management sector may see broader scrutiny of margin pressures.

U.S. waste services stocks could experience modest volatility.

Limited to U.S. equities; no global macro impact.

Counterpoint

Despite the miss, the $263 target suggests upside if margin improvements materialize in FY2027.

Key entities

  • Oppenheimer

    Reiterated Outperform rating and $263 price target for WM.

  • Waste Management

    Reported Q3 results with mixed performance.

Related articles

$WMMed

What Waste Management (WM) Said on Its Q3 Earnings Call

Waste Management (WM) reported Q3 earnings, noting a 1% expected full-year volume decline, with commercial and residential volumes down. Healthcare Solutions revenue grew 3.7%, with EBITDA up 33%. Recycling and renewable energy segments showed strong gains. WM expects strong Q4 margins, despite higher fuel costs. The company returned over 90% of free cash flow to shareholders and completed acquisitions totaling $239M.

$WMHighAI 8/10

Waste Management: Q3 Earnings Snapshot

Waste Management Inc. (WM) reported Q3 earnings of $820M, or $2.05 per share, missing analyst estimates of $2.18 per share. Revenue was $6.85B, exceeding expectations of $6.8B. The company expects full-year revenue between $26.28B and $26.48B.

$WMMedAI 8/10

WM president says ‘we’ve turned a corner’ on healthcare waste profits

WM reported Q3 2026 revenue of $6.84B, up 6.25% YoY, and net income of $820M, up 36% YoY. The Healthcare Solutions segment saw its first YoY revenue increase since the 2024 Stericycle acquisition, with a 33% EBITDA increase. CEO Jim Fish will retire, with President John Morris taking over in January. WM met its healthcare segment's core price and SG&A targets.

$WMMedAI 8/10

WM (WM) Q3 2026 Earnings Call Transcript

WM reported Q3 2026 earnings, with revenue up 6.3%, operating EBITDA up 5.8%, and free cash flow up 20%. CEO Jim Fish announced his retirement, with John Morris succeeding him. The company expects full-year revenue and free cash flow to meet guidance. Health care solutions revenue grew 3.7%, with operating EBITDA up 33%.